摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-Methoxyphenylsulfonyl)-1,5,6,7,8,9-hexahydroazepino[4,5-f]indole | 1087197-90-7

中文名称
——
中文别名
——
英文名称
1-(3-Methoxyphenylsulfonyl)-1,5,6,7,8,9-hexahydroazepino[4,5-f]indole
英文别名
1-(3-methoxyphenyl)sulfonyl-6,7,8,9-tetrahydro-5H-pyrrolo[3,2-h][3]benzazepine
1-(3-Methoxyphenylsulfonyl)-1,5,6,7,8,9-hexahydroazepino[4,5-f]indole化学式
CAS
1087197-90-7
化学式
C19H20N2O3S
mdl
——
分子量
356.445
InChiKey
XPTXBBCZWWFNRD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    68.7
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    tert-butyl 1-((3-methoxyphenyl)sulfonyl)-5,6,8,9-tetrahydroazepino[4,5-f]indole-7(1H)-carboxylate 在 盐酸 作用下, 以 1,4-二氧六环 为溶剂, 生成 1-(3-Methoxyphenylsulfonyl)-1,5,6,7,8,9-hexahydroazepino[4,5-f]indole
    参考文献:
    名称:
    Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists
    摘要:
    Starting from a benzazepine sulfonamide 5-HT(6) receptor antagonist lead with limited brain penetration, application of a strategy of conformational constraint and reduction of hydrogen bond donor count led to a novel series of tricyclic derivatives with high 5-HT(6) receptor affinity and excellent brain: blood ratios. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.08.010
点击查看最新优质反应信息

文献信息

  • Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists
    作者:Giancarlo Trani、Stuart M. Baddeley、Michael A. Briggs、Tsu T. Chuang、Nigel J. Deeks、Christopher N. Johnson、Abir A. Khazragi、Tania L. Mead、Andrew D. Medhurst、Peter H. Milner、Leann P. Quinn、Alison M. Ray、Dean A. Rivers、Tania O. Stean、Geoffrey Stemp、Brenda K. Trail、David R. Witty
    DOI:10.1016/j.bmcl.2008.08.010
    日期:2008.10
    Starting from a benzazepine sulfonamide 5-HT(6) receptor antagonist lead with limited brain penetration, application of a strategy of conformational constraint and reduction of hydrogen bond donor count led to a novel series of tricyclic derivatives with high 5-HT(6) receptor affinity and excellent brain: blood ratios. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多